1-2 of 2
Marcelo Eduardo Zanella Capra, MDPhD
Close
Sort by
Journal Articles

The Impact of Early Molecular Response in Event Free Survival in Patients with Chronic Myeloid Leukemia Treated with Imatinib

Laura Fogliatto, MD, Marcelo Eduardo Zanella Capra, MDPhD, Mariza Shaan, MD, Tito Vanelli Costa, MD, Mayde Seadi Torriani, Luis Carlos Zanandrea Contin, MD, Raquel Breunig, MD, Katia Fassina, MD, Mario Sérgio Fernandes, MD, Denise Almeida, MD, Marco Antônio Schilling, MD, Tânia Hellwig, MD, Tiago Daltoe, MD, Adriana Zardo, MD, Mariangela Moschen, MD, Moema Nene, MD, Juarez Fontoura Silveira, Tahiane Brum Soares, MD, Liane Esteves Daudt, MD PhD, João Friedrisch, Lucia Silla, MD PhD
Journal: Blood
Blood (2014) 124 (21): 5536.
https://doi.org/10.1182/blood.V124.21.5536.5536
Published: 2014
Journal Articles

TKI Treatment Discontinuation: How Many Patients Could Stop Tyrosine Kinase Treatment According to Discontinuation Trials Criteria? Incidence and Prognostic Impact of Deep Molecular Response in a Cohort of Chronic Myeloid Leukemia Patients of South Brazil's Hematology Centers

Laura Fogliatto, MD, Marcelo Eduardo Zanella Capra, MDPhD, Mariza Shaan, MD, Tito Vanelli Costa, MD, Luis Carlos Zanandrea Contin, MD, Raquel Breunig, MD, Juarez Fontoura Silveira, Mayde Seadi Torriani, Katia Fassina, MD, Mario Sergio Fernandes, MD, Denise Almeida, MD, Marco Antonio Schilling, MD, Tânia Hellwig, MD, Tiago Daltoe, MD, Mariangela Moschen, MD, Adriana Zardo, MD, Moema Nene, MD, Liane Esteves Daudt, MD PhD, João Friedrisch, Lucia Silla, MD PhD
Journal: Blood
Blood (2014) 124 (21): 5542.
https://doi.org/10.1182/blood.V124.21.5542.5542
Published: 2014